Clinical Trial Update: Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the combination of brain stimulation and methylphenidate to treat apathy in Alzheimer’s disease/dementia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Alzheimer s Disease, Alzheimer Dementia (AD) | Phase 2 | Status: RECRUITING